Can Januvia (Sitagliptin) Cause Hyponatremia?
No, Januvia (sitagliptin) does not cause hyponatremia and is not associated with this electrolyte disturbance based on FDA labeling and clinical guidelines.
Evidence from FDA Drug Label
The official FDA prescribing information for Januvia 111 provides comprehensive safety data and does not list hyponatremia as a known adverse effect. The documented warnings and precautions include:
- Pancreatitis (postmarketing reports of acute, hemorrhagic, or necrotizing pancreatitis)
- Hypoglycemia (when combined with sulfonylureas or insulin)
- Hypersensitivity reactions (anaphylaxis, angioedema, Stevens-Johnson syndrome)
- Arthralgia (joint pain, including severe and disabling)
- Bullous pemphigoid (postmarketing reports)
Notably absent from this list is any mention of hyponatremia or electrolyte disturbances.
Clinical Guideline Perspective
The 2025 American Diabetes Association guidelines 2 classify DPP-4 inhibitors (including sitagliptin) as having:
- Intermediate glycemic efficacy
- Weight neutral effect
- No hypoglycemia risk (as monotherapy)
- Unknown cardiovascular and renal effects
The guideline specifically notes that pancreatitis and arthralgia are the primary concerns, with no reference to sodium or electrolyte abnormalities.
Important Distinction: SGLT2 Inhibitors vs. DPP-4 Inhibitors
Do not confuse sitagliptin with SGLT2 inhibitors, which have an entirely different mechanism and can actually increase serum sodium levels. Recent evidence demonstrates that SGLT2 inhibitors like empagliflozin are being studied as treatments for hyponatremia in SIADH 34, as they promote osmotic diuresis and electrolyte-free water clearance. This is the opposite mechanism from causing hyponatremia.
Sitagliptin works by inhibiting DPP-4 enzyme, prolonging incretin hormone activity—a completely different pathway that does not affect renal sodium handling or water excretion.
Clinical Bottom Line
If a patient on Januvia develops hyponatremia, look for alternative causes:
- SIADH from other medications, malignancy, or pulmonary disease
- Diuretic use (thiazides are notorious)
- Volume depletion
- Adrenal insufficiency
- Hypothyroidism
- Other concurrent medications
Januvia should not be discontinued for hyponatremia, as it is not the culprit. Focus your diagnostic workup on the actual underlying etiology.